The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An open label, randomized, parallel, phase II trial to evaluate the efficacy and safety of cremophor-free, polymeric micelle formulation of paclitaxel compared to paclitaxel in subjects with ovarian cancer.
Yong-Man Kim
No relevant relationships to disclose
Shin-Wha Lee
No relevant relationships to disclose
Chi Heum Cho
No relevant relationships to disclose
Soo-Young Hur
No relevant relationships to disclose
Byoung-Gie Kim
No relevant relationships to disclose
Jae Hoon Kim
No relevant relationships to disclose
Seung Cheol Kim
No relevant relationships to disclose
Seok-Mo Kim
No relevant relationships to disclose
Young-Tae Kim
No relevant relationships to disclose
Hee Sug Ryu
No relevant relationships to disclose
Soon-Beom Kang
No relevant relationships to disclose